Abstract
ObjectiveDesmoplasia and hypovascularity are thought to impede drug delivery in pancreatic ductal adenocarcinoma (PDAC). However, stromal depletion approaches have failed to show clinical responses in patients. Here, we aimed to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have